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Quantification and Manipulation of MHC-I Delivery to Cell Plasma
Membrane
Daniel Blumenthal.
An invaded cell reports to the immune system it has been compromised by a pro-
cess involving clustering ofMajorHistocompatibility ComplexClass I (MHC-I)
protein on the cell membrane surface. In our work we
concentrated on the mechanism by which MHC-I is
trafficked to the cell membrane; although predictions
existed, the dynamics of the reporting processes were
not fully understood for the past 15 years. Using Total
Internal Reflection FluorescenceMicroscopy (TIRFM)
in combination with sophisticated image analysis pro-
cedures, we quantified the rate of delivery of MHC-I
to the plasma membrane. Additionally, we developed
a simple way to control (reduce) the delivery rate. Fur-
thermore, we provide supporting evidence for the fact
that MHC-I are primarily trafficked in Clathrin-
coated vesicles.Membrane Transporters & Exchangers II
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Transporting Mechanisms of Sodium-Dependent Secondary Membrane
Transporters: Insights form Computational Simulations
Chunfeng Zhao, Javier Cuervo, Sergei Y. Noskov.
Recent progress in crystallographic studies of sodium-coupled secondary
transporters has revealed striking similarities in the structural organization
of ion and solute binding motifs and a well-conserved inverted-repeat topol-
ogy between proteins from several gene families. Molecular Dynamics and
free energy simulations are applied to study the mechanisms of selective bind-
ing of ion and substrate in LeuT, vSGLT, and Mhp1. We found that water
molecules accessed from periplasm and cytoplasm to the binding sites play
an important role in affinity and selectivity of the ion/substrate binding. String
method is applied to study the transition from outward-facing state to inward-
facing state, providing a minimal-free energy pathway of the transition. These
studies identify the sequence of ion and substrate binding/releasing associated
with the transporting cycle and provide microscopic mechanical mechanisms
of gating.2230-Pos Board B216
On How the Conformational Cycle of the AcrB Efflux Pump is Coupled to
Proton Translocation: A Theoretical Study Based on High-Resolution
Structural Data
Claudio Anselmi, Wenchang Zhou, Kay Diederichs, Klaas M. Pos,
Jose´ D. Faraldo-Go´mez.
The AcrA/AcrB/TolC multidrug efflux pump confers Escherichia coli with an-
tibiotic resistance by sequestering toxic compounds found within the periplasm
and inner membrane and extruding them into the extracellular space. The AcrB
trimer is the central component of this efflux complex; anchored in the inner
membrane, it forms an asymmetric assembly that undergoes a conformational
cycle in which each protomer adopts three different structures. As a result, sub-
strates bound in the periplasmic domain of AcrB are projected into the TolC
channel, which reaches beyond the outer membrane. Crucially, the conforma-
tional cycle within AcrB is driven by the translocation of protons down the gra-
dient sustained by the inner membrane, through a mechanism that has not been
characterized so far.
Here, we investigate this microscopic mechanism through atomistic free-
energy molecular dynamics simulations and electrostatic calculations, based
upon novel high-resolution structural data for wild-type and mutagenized
AcrB. Specifically, we assess the events associated with binding and release
of protons within the membrane domain, and determine the mechanism by
which these events are coupled to the reorganization of key transmembrane he-
lices within each protomer. This investigation reveals how proton translocation
influences both local and remote interactions within the protein, thereby mod-
ulating its structure.
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Mechanism of Intracellular Gating in the Glutamate Transporter
Zhijian Huang, Emad Tajkhorshid.
Glutamate transporters (GlTs) are membrane proteins that regulate and remove
synaptically released neurotransmitter glutamate, and maintain normal excit-atory synaptic transmission. The recently solved structure of inward-facing
GltPh, a GlT homologue revealed an occluded state with the substrate and
two Naþ ions (Na1 and Na2) bound.
The inward-facing and outward-facing structures of GltPh have put forward
a molecular mechanism by which the transporter mediates Naþ-coupled sub-
strate uptake. However, the molecular nature of the intracellular gate and the
mechanism of gating are still unknown. Furthermore, the mechanism of release
of the substrate and co-transported Naþ ions from their intracellular binding
sites remains elusive. We have investigated the transporter’s dynamics and
the coupling between substrate and Naþ ions using an extensive set of molec-
ular dynamics simulations of membrane-embedded model of inward-facing
GltPh in various bound states. The results suggest that the helical hairpin
HP1 plays the key role of the intracellular gate for the substrate-binding site,
and that the opening and closure of the gate is controlled by the Naþ ion in
the Na1 site. The Naþ ion in the Na2 site was found to be the first to be released
from the inward-facing occluded state and can diffuse into the cytoplasmic so-
lution through the attraction of highly conserved residue Ser65 in TM2. More-
over, upon unbinding of the Naþ ion in the Na1 site, the substrate was observed
to completely unbind from the binding site and diffuse into the cytoplasmic so-
lution in our equilibrium simulations along the opening of the intracellular gate
HP1. Based on the simulations, we propose that the two structurally resolved
Naþ ions release into the cytoplasm froe the inward-facing Gltph before the
substrate.
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Looking for the Inward Facing State of Glutamate Transporters
Xiaoyu Wang, Marta Rodriguez, Peter Larsson.
A recent crystal structure of the bacterial glutamate transporter homologue
GltPh (Reyes et al., 2009) was interpreted as the inward facing state of gluta-
mate transporter. Comparing this inward facing structure to the earlier outward
facing structures of GltPh suggested that glutamate transporters undergo a large
conformational change between these two states. In contrast, earlier FRET ex-
periments from our group (Koch and Larsson, 2005) suggested that the mam-
malian glutamate transporter EAAT3 does not undergo large conformational
changes during the uptake cycle. We here tested the proposed inward facing
state of glutamate transporters using different FRET techniques under different
ion and substrate conditions that, we assume, forces EAAT3 to mainly occupy
the inward facing state or the outward facing state.
Ryanodine Receptors
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Ryanodine Receptor is a Magnesium Channel: Consequences of Selectivity
on Physiology
Dirk Gillespie.
The ryanodine receptor (RyR) releases Ca2þ out of the sacroplasmic reticulum
(SR) and is therefore thought of a calcium channel. However, the most abun-
dant divalent cation is Mg2þ (present at ~1 mM both in the cytoplasm and
the SR) and RyR has a very high affinity for symmetrically applied Mg2þ.
This is seen in single-channel recordings when even 1 mM of symmetric
Mg2þ reduces the current from 10 mM luminal Ca2þ by ~25%. Here it is shown
why changes in [Mg2þ] (e.g., due to ischemia or exercise) disproportionately
affect unitary Ca2þ current, in addition to changing RyR open probability. A
recent model of ion permeation through RyR is used to first describe the mech-
anism behind this high Mg2þ affinity and RyR’s weak Kþ affinity and then an-
alyze their effect on Ca2þ release. Loosely speaking, [Kþ] defines the SR
membrane potential and [Mg2þ] defines unitary Ca2þ current for a fixed SR
membrane potential and SR Ca2þ load. Counterintuitively, while Kþ occu-
pancy in the pore is low, Kþ still provides the vast majority of countercurrent
during Ca2þ release. Moreover, the opposite is true for Mg2þ; unless [Mg2þ] is
unusually high, Mg2þ provides little countercurrent despite having the largest
number of ions in the pore.
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Ouabain is a Pharmacomimic of Mutant RyR2 Ca2þ Release Dysfunction
but is not a Serum-Borne Trigger of CPVT
Steven R. Barberini-Jammaers, Nicole C. Silvester, Ben H. Maskrey,
Gabriele Banci, Raffaella Bloise, Mark C. Bagley, Valerie B. O’Donnell,
Carlo Napolitano, Silvia G. Priori, F. Anthony Lai, Christopher H. George.
Mutation-linked RyR2 Ca2þ handling dysfunction is an intracellular driver for
stress-evoked arrhythmias. Disease pathogenesis links augmented b-adrenergic
stimulation to the acute dysfunction of mutant RyR2. However, the incomplete
efficacy of b-blockade in clinical and experimental scenarios suggests that
other serum-borne factors, in addition to catecholamines, contribute to Ca2þ
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ilar to that elicited by digitalis toxicity and a related glycoside, ouabain, has
been identified as an endogenous Ca2þ-mobilising ‘hormone’. Circulating
levels of adrenally-derived ouabain are reportedly elevated in heart failure
and post-exercise. Here we investigated whether physiologic levels of ouabain
could provoke mutant RyR2 channel dysfunction. In single HL-1 cardiomyo-
cytes, ouabain (EC50 = 14.3nM) perturbed Ca2þ homeostasis in a manner
strikingly similar to that determined in cells expressing CPVT-linked
R4497C mutation. Moreover, dose-dependent ouabain-evoked Ca2þ dysfunc-
tion resulted in a left-shifted caffeine activation profile typical of mutant RyR2
channels. LC/MS/MS analysis determined equivalent levels of ouabain in se-
rum obtained from CPVT- and normal subjects (500-800pM) and exercise
stress-testing did not acutely elevate ouabain levels in either cohort. In cells ex-
pressing the R4497C mutation, which exhibited basal Ca2þ dysfunction, addi-
tion of ouabain at physiologic (1nM) and supra-physiologic (10-100nM)
concentrations did not further exacerbate cellular Ca2þ abnormalities. In con-
trast, the addition of serum obtained from exercised normal and CPVT subjects
(100ug protein equivalents; ~2pM ouabain) evoked hallmark mutation-linked
RyR2 dysfunction that was not completely abolished by b-blockade. These
findings confirm that non-catecholaminergic factors contribute to RyR2 mutant
dysfunction, but preclude the possibility that endogenous ouabain is a physio-
logically relevant trigger of CPVT. However, the hypothesis that endogenous
ouabain may induce underlying changes in excitation-contraction coupling
that increase the propensity for mutation-linked RyR2 dysfunction is being
investigated.
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The Effect of Adrenergic Stimulation on the Calcium Release Channel
Jiao Li, Nicole A. Beard, Angela F. Dulhunty, Dirk F. vanHelden,
Derek R. Laver.
Adrenergic stimulation of the heart involves phosphorylation of many intracel-
lular Ca2þ handling proteins including the ryanodine receptor Ca2þ release
channels in the SR (RyRs). It is known that RyRs can be phosphorylated at
three serine residues at 2808, 2814 and 2030 and that phosphorylation of
RyRs via PKA causes an increase in RyR activity in situ. However, little is
known about how phosphorylation of RyRs in the cell alters their regulation
by intracellular Ca2þ and Mg2þ.
RyRs were isolated from rat hearts, which had been rapidly removed, perfused
with Krebs buffer in a Langendorff apparatus. Some hearts were perfused with
1 mM isoproterenol for sufficient time to increase heart rate by>60% for 1 min
and others without isoproterenol for 5 mins. Hearts were snap frozen in liquid
N2 to capture their state of phosphorylation, thus allowing RyRs to be phos-
phorylated by the physiological signalling processes. RyRs were incorporated
into artificial planar lipid bilayers and their activity was measured using single
channel recording.
The activity of RyRs from isoproterenol stimulated hearts (ISO RyRs, n=25)
was 3-fold higher than control RyRs (n=24) at diastolic [Ca2þ] (100 nM) but
was not significantly different at systolic [Ca2þ] (>1 mM). At diastolic
[Ca2þ], addition of Protein Phosphatase1 (PP1, 5 mins) reduced the activity
of ISO RyRs by 98 5 2.6% (n=4) and control RyRs by 70 5 20 % (n=4)
but this treatment had no effect at systolic [Ca2þ]. ISO RyRs displayed
a 100-fold channel-to-channel variation in activity which was larger than,
and encompassed the range of activity seen either for control RyRs or PP1
treated RyRs. The results indicate that adrenergic stimulation increases RyR2
activity during diastole but not during systole.
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The Functional Impact of Cis Acting Ryanodine Receptor Type 1
Mutations in a Child with a Fatal Spontaneous MH Event
Linda Groom, Sheila Muldoon, Munkhuu Bayarsaikhan, Saiid Bina,
Hee-Suk Lee, Barbara W. Brandom, Nyamkhishig Sambuughin,
Robert T. Dirksen.
Mutations in the RYR1 gene result in MH, a pharmacogenetic disorder of
skeletal muscle typically triggered by administration of anesthetics. How-
ever, cases of sudden death during exertion, heat challenge, and febrile ill-
ness in the absence of triggering drugs have been reported in individuals
with RYR1 gene variants. We describe the clinical history and genetic anal-
ysis of a child that suffered a fatal, non-anesthetic MH episode associated
with febrile illness who was heterozygous for two novel RYR1 variants
where one variant, R3983C, occurred de-novo and another, D4505H, was in-
herited. Effects of the two variants on RYR1 sensitivity to activation by caf-
feine were assessed following expression in RYR1-null myotubes. The
single (R3983C and D4505H) and double (R3983C-D4505H) variants
were engineered into a full-length rabbit RYR1 cDNA and introduced
into RyR1-null myotubes via nuclear microinjection. Effects of the differentheterotypic expression conditions (WTþR3983C, WTþD4505H,
R3983CþD4505H, and WTþR3983C-D4505H) on RYR1 activation by caf-
feine were determined in indo-1-loaded myotubes. Compared to WT RYR1
alone (EC50 = 1.5 mM), the caffeine sensitivity of RYR1 Ca
2þ release was
only modestly increased following co-expression of either R3983C (EC50 =
1.3 mM) or D4505H (EC50 = 0.9 mM). Remarkably, co-expression of WT
RYR1 with the double mutant in cis (R3983C-D4505H) produced a much
stronger sensitization of caffeine-induced release (EC50 = 0.3) than that ob-
served following co-expression of the two variants on separate subunits
(EC50 = 0.9). Thus, the R3893C mutation potentiates D4505H-mediated sen-
sitization of caffeine-induced RYR1 Ca2þ release when these mutations are
in cis or present on the same subunit, but not when present on separate sub-
units. These results indicate that allelic segregation can be a critical, and
heretofore unappreciated, pathogenic factor in compound heterozygous
MH individuals.
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GSTM2 C Terminus Reduces Calcium Release Through RyR2 in Sponta-
neously Contracting and Field Stimulated Ventricular Cardiomyocytes
Ruwani P. Hewawasam, Marco G. Casarotto, Philip G. Board,
Angela F. Dulhunty.
The ryanodine receptor (RyR) is an ion channel that releases Ca2þ from the sar-
coplasmic reticulum and is essential for excitation-contraction coupling and
contraction in striated muscle. Previously we reported that the human muscle
specific glutathione transferase (GSTM2-2) is an inhibitor of cardiac muscle
RyR2 and a weak activator of skeletal muscle RyR1. Single channel experi-
ments and Ca2þ release assays using the C-terminal half of GSTM2-2
(GSTM2C) and the mutants, F157A and Y160A in the C terminal domain con-
firmed the importance of helix 6 in the C-terminal (non-enzymic) fold for in-
hibition of RyR2. The objective of this study was to determine the effect of
GSTM2C on the cardiac myocyte function.
Primary cardiomyocytes were cultured from neonatal rats. Spontaneous or
field- stimulated (1Hz with 3V, 2ms pulses) contraction was recorded in control
and 15mMGSTM2C-treated cells using a JVC video camera KY/F550 attached
to Nikon TE2000-U microscope. Images were analysed using Image Pro plus
6.2 software and percentage cell shortening measured.
Preliminary results showed that spontaneous contraction frequency fell from
42.5/min in the control group to 6.9 /min after GSTM2C treatment
(P<0.001). The number of spontaneously beating cells fell from 6.6% in the
control group to 1.9% after treatment (P<0.001). To determine whether the re-
duced contractions were due to the GSTM2 C terminus affecting action poten-
tials or contraction, shortening was measured. Shortening in spontaneous
contraction fell from 7.551.0% in control to 2.950.6% after GSTM2C treat-
ment (P<0.001). Shortening after field stimulation also fell, from 7.350.8%
before to 4.150.6% after, GSTM2C-treatment (P<0.01). These results are
consistent with GSTM2 C reducing contraction in ventricular cardiomyocytes
by reducing Ca2þ release through RyR2.
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In Situ Measurement of RyR2-Calmodulin Binding in Permeabilized
Cardiomyocytes
Yi Yang, Asima Chakraborty, Tao Guo, Razvan L. Cornea,
Gerhard Meissner, Donald M. Bers.
Calmodulin (CaM) is a Ca-sensing protein and important regulator to RyR2.
Defective CaM association with and regulation of RyR2 has been implicated
in cardiac hypertrophy, heart failure and Catecholaminergic Polymorphic Ven-
tricular Tachycardia. However, direct measurement of the RyR-CaM binding
properties in myocytes is lacking despite its potential clinical importance.
This is most likely due to the interference from CaM’s multiple binding targets,
such as L-type Ca channel, Calcineurin, and CaMKII. Fluorescence Resonance
Energy Transfer (FRET) was used to measure the RyR2-specific bound CaM in
permeabilized rat and mouse cardiomycytes. FKBP12.6 and CaM bind to RyR2
in close physical proximity so that strong FRET can be detected between fluo-
rescently labeled FKBP12.6 (F-FKBP12.6) and F-CaM. To confirm the speci-
ficity of CaM binding to RyR2 and measure the percentage of CaM visible at
the Z-line is RyR-bound under physiological conditions, we used mutant RyR2
knock-in mice expressing a triple mutation in the RyR2 (RyR2ADA). The mu-
tation prevents CaM binding to RyR2 but should not alter binding of CaM to
other targets. Our data showed that 1) the apparent Kd of CaM to RyR in rat
cardiac myocytes (at 100 nM [Ca]) was 18.25 2nM (n=XX); 2) heterozygous
RyR2ADA/þ mutation decreased the maximal binding sites (on RyR2) by 50%
without appreciably altering affinity in mouse myocytes (Kd =16.95XX nM in
RyR2ADA/þ and 13.45XX nM, inWTmice, p< 0.05); 3) The total CaM bind-
ing visible at the Z-line was reduced by 45%, implying that ~90% of Z-line
